Logo image of SUZ

SUZANO SA - SPON ADR (SUZ) Stock Fundamental Analysis

NYSE:SUZ - US86959K1051 - ADR

9.63 USD
+0.1 (+1.05%)
Last: 9/5/2025, 8:04:00 PM
9.63 USD
0 (0%)
After Hours: 9/5/2025, 8:04:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to SUZ. SUZ was compared to 9 industry peers in the Paper & Forest Products industry. While SUZ has a great profitability rating, there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on SUZ. These ratings could make SUZ a good candidate for value investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year SUZ was profitable.
SUZ had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: SUZ reported negative net income in multiple years.
Each year in the past 5 years SUZ had a positive operating cash flow.
SUZ Yearly Net Income VS EBIT VS OCF VS FCFSUZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B

1.2 Ratios

The Return On Assets of SUZ (4.91%) is better than 66.67% of its industry peers.
SUZ has a Return On Equity of 18.14%. This is in the better half of the industry: SUZ outperforms 77.78% of its industry peers.
SUZ has a Return On Invested Capital of 7.05%. This is in the better half of the industry: SUZ outperforms 77.78% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SUZ is above the industry average of 5.72%.
Industry RankSector Rank
ROA 4.91%
ROE 18.14%
ROIC 7.05%
ROA(3y)7.7%
ROA(5y)3.96%
ROE(3y)26.78%
ROE(5y)-2.15%
ROIC(3y)9.38%
ROIC(5y)9.39%
SUZ Yearly ROA, ROE, ROICSUZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

SUZ has a Profit Margin of 15.26%. This is amongst the best in the industry. SUZ outperforms 100.00% of its industry peers.
The Operating Margin of SUZ (25.74%) is better than 100.00% of its industry peers.
In the last couple of years the Operating Margin of SUZ has grown nicely.
SUZ has a better Gross Margin (37.73%) than 100.00% of its industry peers.
SUZ's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 25.74%
PM (TTM) 15.26%
GM 37.73%
OM growth 3Y-8.96%
OM growth 5Y26.2%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.3%
GM growth 5Y15.81%
SUZ Yearly Profit, Operating, Gross MarginsSUZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

5

2. Health

2.1 Basic Checks

SUZ has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, SUZ has less shares outstanding
Compared to 5 years ago, SUZ has less shares outstanding
SUZ has a worse debt/assets ratio than last year.
SUZ Yearly Shares OutstandingSUZ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
SUZ Yearly Total Debt VS Total AssetsSUZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

SUZ has an Altman-Z score of 1.25. This is a bad value and indicates that SUZ is not financially healthy and even has some risk of bankruptcy.
SUZ has a Altman-Z score of 1.25. This is in the lower half of the industry: SUZ underperforms 66.67% of its industry peers.
SUZ has a debt to FCF ratio of 17.09. This is a negative value and a sign of low solvency as SUZ would need 17.09 years to pay back of all of its debts.
SUZ has a Debt to FCF ratio (17.09) which is comparable to the rest of the industry.
A Debt/Equity ratio of 2.20 is on the high side and indicates that SUZ has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 2.20, SUZ is doing worse than 77.78% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.2
Debt/FCF 17.09
Altman-Z 1.25
ROIC/WACC1.05
WACC6.72%
SUZ Yearly LT Debt VS Equity VS FCFSUZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B 80B

2.3 Liquidity

SUZ has a Current Ratio of 3.16. This indicates that SUZ is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of SUZ (3.16) is better than 100.00% of its industry peers.
SUZ has a Quick Ratio of 2.48. This indicates that SUZ is financially healthy and has no problem in meeting its short term obligations.
SUZ has a better Quick ratio (2.48) than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.16
Quick Ratio 2.48
SUZ Yearly Current Assets VS Current LiabilitesSUZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 3877.50% over the past year.
Looking at the last year, SUZ shows a very strong growth in Revenue. The Revenue has grown by 27.38%.
SUZ shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.75% yearly.
EPS 1Y (TTM)3877.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%236.73%
Revenue 1Y (TTM)27.38%
Revenue growth 3Y4.99%
Revenue growth 5Y12.75%
Sales Q2Q%15.68%

3.2 Future

SUZ is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 52.36% yearly.
Based on estimates for the next years, SUZ will show a quite strong growth in Revenue. The Revenue will grow by 15.19% on average per year.
EPS Next Y248.01%
EPS Next 2Y80.84%
EPS Next 3Y52.36%
EPS Next 5YN/A
Revenue Next Year10.13%
Revenue Next 2Y13.56%
Revenue Next 3Y11.71%
Revenue Next 5Y15.19%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
SUZ Yearly Revenue VS EstimatesSUZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20B 40B 60B 80B
SUZ Yearly EPS VS EstimatesSUZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 -10

9

4. Valuation

4.1 Price/Earnings Ratio

SUZ is valuated reasonably with a Price/Earnings ratio of 8.16.
Based on the Price/Earnings ratio, SUZ is valued cheaper than 100.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.06, SUZ is valued rather cheaply.
SUZ is valuated cheaply with a Price/Forward Earnings ratio of 7.42.
Based on the Price/Forward Earnings ratio, SUZ is valued cheaper than 88.89% of the companies in the same industry.
SUZ is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.69, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.16
Fwd PE 7.42
SUZ Price Earnings VS Forward Price EarningsSUZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SUZ is valued a bit cheaper than the industry average as 77.78% of the companies are valued more expensively.
SUZ's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. SUZ is cheaper than 77.78% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.22
EV/EBITDA 5.69
SUZ Per share dataSUZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SUZ has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as SUZ's earnings are expected to grow with 52.36% in the coming years.
PEG (NY)0.03
PEG (5Y)N/A
EPS Next 2Y80.84%
EPS Next 3Y52.36%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.28%, SUZ has a reasonable but not impressive dividend return.
SUZ's Dividend Yield is a higher than the industry average which is at 3.54.
With a Dividend Yield of 1.28, SUZ pays less dividend than the S&P500 average, which is at 2.41.
Industry RankSector Rank
Dividend Yield 1.28%

5.2 History

On average, the dividend of SUZ grows each year by 20.94%, which is quite nice.
SUZ has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of SUZ decreased recently.
Dividend Growth(5Y)20.94%
Div Incr Years1
Div Non Decr Years1
SUZ Yearly Dividends per shareSUZ Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2022 2023 2024 0.2 0.4 0.6

5.3 Sustainability

SUZ pays out 32.13% of its income as dividend. This is a sustainable payout ratio.
The dividend of SUZ is growing, but earnings are growing more, so the dividend growth is sustainable.
DP32.13%
EPS Next 2Y80.84%
EPS Next 3Y52.36%
SUZ Yearly Income VS Free CF VS DividendSUZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B
SUZ Dividend Payout.SUZ Dividend Payout, showing the Payout Ratio.SUZ Dividend Payout.PayoutRetained Earnings

SUZANO SA - SPON ADR

NYSE:SUZ (9/5/2025, 8:04:00 PM)

After market: 9.63 0 (0%)

9.63

+0.1 (+1.05%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-06 2025-11-06/bmo
Inst Owners27.26%
Inst Owner Change4.98%
Ins Owners15.51%
Ins Owner ChangeN/A
Market Cap11.90B
Analysts82.73
Price Target13.95 (44.86%)
Short Float %0.44%
Short Ratio1.69
Dividend
Industry RankSector Rank
Dividend Yield 1.28%
Yearly Dividend0.24
Dividend Growth(5Y)20.94%
DP32.13%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)104.78%
Min EPS beat(2)12.88%
Max EPS beat(2)196.69%
EPS beat(4)3
Avg EPS beat(4)-81.54%
Min EPS beat(4)-569.87%
Max EPS beat(4)196.69%
EPS beat(8)6
Avg EPS beat(8)-62.1%
EPS beat(12)9
Avg EPS beat(12)-31.22%
EPS beat(16)12
Avg EPS beat(16)-21.71%
Revenue beat(2)1
Avg Revenue beat(2)-2.86%
Min Revenue beat(2)-6.63%
Max Revenue beat(2)0.92%
Revenue beat(4)2
Avg Revenue beat(4)-0.34%
Min Revenue beat(4)-6.63%
Max Revenue beat(4)6.32%
Revenue beat(8)5
Avg Revenue beat(8)-0.03%
Revenue beat(12)7
Avg Revenue beat(12)-0.52%
Revenue beat(16)10
Avg Revenue beat(16)-0.12%
PT rev (1m)1.45%
PT rev (3m)1.11%
EPS NQ rev (1m)-40.83%
EPS NQ rev (3m)-51.61%
EPS NY rev (1m)-15.01%
EPS NY rev (3m)-15.03%
Revenue NQ rev (1m)-3.9%
Revenue NQ rev (3m)-7.78%
Revenue NY rev (1m)-0.2%
Revenue NY rev (3m)-6.83%
Valuation
Industry RankSector Rank
PE 8.16
Fwd PE 7.42
P/S 1.26
P/FCF 11.22
P/OCF 3.19
P/B 1.5
P/tB 2.17
EV/EBITDA 5.69
EPS(TTM)1.18
EY12.25%
EPS(NY)1.3
Fwd EY13.48%
FCF(TTM)0.86
FCFY8.92%
OCF(TTM)3.02
OCFY31.35%
SpS7.65
BVpS6.43
TBVpS4.43
PEG (NY)0.03
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.91%
ROE 18.14%
ROCE 8.99%
ROIC 7.05%
ROICexc 8.18%
ROICexgc 9.16%
OM 25.74%
PM (TTM) 15.26%
GM 37.73%
FCFM 11.22%
ROA(3y)7.7%
ROA(5y)3.96%
ROE(3y)26.78%
ROE(5y)-2.15%
ROIC(3y)9.38%
ROIC(5y)9.39%
ROICexc(3y)11.06%
ROICexc(5y)11.2%
ROICexgc(3y)12.82%
ROICexgc(5y)13.35%
ROCE(3y)11.96%
ROCE(5y)11.98%
ROICexcg growth 3Y-17.29%
ROICexcg growth 5Y26.8%
ROICexc growth 3Y-14.86%
ROICexc growth 5Y30.34%
OM growth 3Y-8.96%
OM growth 5Y26.2%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.3%
GM growth 5Y15.81%
F-Score7
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 2.2
Debt/FCF 17.09
Debt/EBITDA 4
Cap/Depr 138.59%
Cap/Sales 28.23%
Interest Coverage 2.36
Cash Conversion 85.57%
Profit Quality 73.57%
Current Ratio 3.16
Quick Ratio 2.48
Altman-Z 1.25
F-Score7
WACC6.72%
ROIC/WACC1.05
Cap/Depr(3y)212.09%
Cap/Depr(5y)160.32%
Cap/Sales(3y)37.3%
Cap/Sales(5y)28.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3877.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%236.73%
EPS Next Y248.01%
EPS Next 2Y80.84%
EPS Next 3Y52.36%
EPS Next 5YN/A
Revenue 1Y (TTM)27.38%
Revenue growth 3Y4.99%
Revenue growth 5Y12.75%
Sales Q2Q%15.68%
Revenue Next Year10.13%
Revenue Next 2Y13.56%
Revenue Next 3Y11.71%
Revenue Next 5Y15.19%
EBIT growth 1Y18.91%
EBIT growth 3Y-4.42%
EBIT growth 5Y42.3%
EBIT Next Year76.21%
EBIT Next 3Y28.29%
EBIT Next 5Y20.91%
FCF growth 1Y71.41%
FCF growth 3Y-30.27%
FCF growth 5Y9.93%
OCF growth 1Y-7.35%
OCF growth 3Y5.32%
OCF growth 5Y22.15%